Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report

被引：0

作者：

Meng-Yun Li

Zhi-Hong Lin

Ming-Ming Hu

Li-Qing Kang

Xiao-xia Wu

Qi-wei Chen

Xin Kong

Jian Zhang

Hui-Ying Qiu

De-Pei Wu

机构：

[1] The First Affiliated Hospital of Soochow University,Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Collaborative Innovation Center of Hematology

[2] Institute of Blood and Marrow Transplantation,Institute of Biomedical Engineering and Technology, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development

[3] Soochow University,undefined

[4] Suzhou Yongding Hospital,undefined

[5] School of Chemistry and Molecular Engineering,undefined

[6] East China Normal University,undefined

[7] Shanghai Unicar-Therapy Bio-medicine Technology Co.,undefined

[8] Ltd,undefined

来源：

Biomarker Research | / 8卷

关键词：

CD19; Chimeric antigen receptor T cells; Donor-derived; Humanized; Mixed phenotype acute leukemia;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] DONOR-DERIVED, CD19-DIRECTED, CAR-MODIFIED T CELLS INFUSED AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION AS PRE-EMPTIVE DONOR LYMPHOCYTE INFUSION IN PATIENTS WITH CD19+MALIGNANCIES
Kebriaei, P.
Huls, H.
Ciurea, S.
Liu, T.
Singh, H.
Su, S.
Hosing, C.
Olivares, S.
Figliola, M.
Kumar, P.
Jena, B.
Maiti, S.
McNiece, I.
Lee, D.
Tewari, P.
Popat, U.
Alousi, A.
Oran, B.
Shah, N.
Rezvani, K.
Forget, M.
Ang, S.
Jackson, R.
Rondon, G.
Kantarjian, H.
Hackett, P.
Shpall, E.
Champlin, R.
Cooper, L.
HAEMATOLOGICA, 2015, 100 : 320 - 320
[42] Secondary donor-derived CD19 CAR-T therapy is safe and efficacious in acute lymphoblastic leukemia with extramedullary relapse after first autologous CAR-T therapy
Kong, Delin
Yang, Tingting
Geng, Jia
Jing, Ruirui
Zhang, Qiqi
Wei, Guoqing
Huang, He
Hu, Yongxian
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2022, 23 (10): : 876 - 880
[43] Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL
del Bufalo, Francesca
Becilli, Marco
Rosignoli, Chiara
De Angelis, Biagio
Algeri, Mattia
Hanssens, Linda
Gunetti, Monica
Iacovelli, Stefano
Li Pira, Giuseppina
Girolami, Elia
Leone, Giovanna
Lazzaro, Stefania
Bertaina, Valentina
Sinibaldi, Matilde
Di Cecca, Stefano
Iaffaldano, Laura
Kunkele, Annette
Boccieri, Emilia
Del Baldo, Giada
Pagliara, Daria
Merli, Pietro
Carta, Roberto
Quintarelli, Concetta
Locatelli, Franco
BLOOD, 2023, 142 (02) : 146 - 157
[44] Venetoclax-azacitidine as salvage therapy for relapsed mixed phenotype acute leukemia after a second allogeneic hematopoietic stem cell transplantation: a case report
Mekni, Sabrine
Kanoun, Rimmel Yosra
Ladeb, Saloua
Belloumi, Dorra
Ben Abdeljelil, Nour
Ben Othman, Tarek
BLOOD RESEARCH, 2023, 58 (02) : 118 - 120
[45] Prophylactic or Preemptive Donor-Derived CD19 CAR-T Cell Infusion for Preventing Relapse in High-Risk B-ALL after Allogeneic Hematopoietic Stem Cell Transplantation
Lu, Wenyi
Zhang, Meng
Lv, Hairong
Xiao, Xia
Bai, Xue
Wang, Jiaxi
Pu, Yedi
Meng, Juanxia
Zhang, Xiaomei
Zhu, Haibo
Yuan, Ting
Wang, Bing
Jin, Xin
Cao, Xinping
Wang, Zhao
Xie, Tianle
Meng, Haotian
Stepanov, Alexey
Gabibov, Alexander G.
An, Yuxin
Sun, Rui
Zhang, Yu
Maschan, Mikhail A.
Zhu, Zunmin
Zhang, Hongkai
Zhao, Mingfeng
BLOOD, 2023, 142
[46] CD19-CAR-T Therapy Followed By Allogeneic Hematopoietic Stem Cell Transplantation in Refractory/Relapsed and High Risk B-Cell Acute Lymphoblastic Leukemia
Zhao, Yanli
Zhang, Jianping
Liu, Deyan
Xiong, Min
Wei, Zhijie
Sun, Ruijuan
Zhou, Jiarui
Lu, Yue
Cao, Xingyu
Yang, Junfang
Zhang, Xian
Wang, Hui
Liu, Hongxing
Lu, Peihua
Lu, Daopei
BLOOD, 2018, 132
[47] Long-Term Outcomes Following Donor-Derived Anti-CD19 CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia Patients Relapsed after Allogenic Stem Cell Transplantation
Zhang, Rongli
Wang, Ying
Zou, Dehui
Jiang, Erlie
He, Yi
Yang, Donglin
Feng, Sizhou
Wang, Jianxiang
Han, Ming-Zhe
BLOOD, 2020, 136
[48] Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation
Lussana, Federico
Magnani, Chiara F.
Galimberti, Stefania
Gritti, Giuseppe
Gaipa, Giuseppe
Belotti, Daniela
Cabiati, Benedetta
Napolitano, Sara
Ferrari, Silvia
Moretti, Alex
Buracchi, Chiara
Borleri, Gian Maria
Rambaldi, Benedetta
Rizzuto, Giuliana
Grassi, Anna
Paganessi, Muriel
Meli, Cristian
Tettamanti, Sarah
Risca, Giulia
Pais, Giulia
Spinozzi, Giulio
Benedicenti, Fabrizio
Cazzaniga, Giovanni
Capelli, Chiara
Gotti, Elisa
Introna, Martino
Golay, Josee
Montini, Eugenio
Balduzzi, Adriana
Valsecchi, Maria Grazia
Dastoli, Giuseppe
Rambaldi, Alessandro
Biondi, Andrea
BLOOD CANCER JOURNAL, 2025, 15 (01):
[49] Humanized CD19-targeted chimeric antigen receptor T (CAR-T) cells for relapsed/refractory pediatric acute lymphoblastic leukemia
Wang, Shiyuan
Wang, Xue
Ye, Chunying
Cheng, Hai
Shi, Ming
Chen, Wei
Qi, Kunming
Wang, Gang
Wu, Qingyun
Zeng, Lingyu
Li, Zhenyu
Jing, Guangjun
Zheng, Junnian
Xu, Kailin
Cao, Jiang
AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (05) : E162 - E165
[50] Success of donor-derived CAR-T cells after failure of autologous CD19 CAR-T cells (tisagenlecleucel) in B-cell acute lymphoblastic leukaemia
Dourthe, Marie Emilie
Yakouben, Karima
David, Audrey
Thouvenin, Sandrine
Chaillou, Delphine
Caillat-Zucman, Sophie
Cuffel, Alexis
Tardy, Clea
Lainey, Elodie
Caye-Eude, Aurelie
Arfeuille, Chloe
Delaugerre, Constance
Chaix-Baudier, Marie-Laure
Naudin, Jerome
Auvin, Stephane
Bergaoui, Karim
Merlat-Guitard, Anne-Isabelle
De Jorna, Romain
Mebarki, Miryam
Dalle, Jean-Hugues
Baruchel, Andre
BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (01) : 373 - 377

← 1 2 3 4 5 →